{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:03:05Z","timestamp":1791028985671,"version":"4.1.0"},"publisher-location":"Totowa, NJ","reference-count":33,"publisher":"Humana Press","isbn-type":[{"value":"9781627035408","type":"print"},{"value":"9781627035415","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-62703-541-5_10","type":"book-chapter","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T19:49:15Z","timestamp":1375386555000},"page":"173-187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Protocols for Lysine Conjugation"],"prefix":"10.1007","author":[{"given":"Marie-Priscille","family":"Brun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Gauzy-Lazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"10_CR00101","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1021\/bi00741a019","volume":"12","author":"RR Traut","year":"1973","unstructured":"Traut RR, Bollen A, Sun T-T, Hershey WB, Sundberg J, Pierce LR (1973) Methyl 4-mercaptobutyrimidate as a cleavable cross-linking reagent and its application to Escherichia coli 30S ribosome. Biochemistry 12:3266\u20133273","journal-title":"Biochemistry"},{"key":"10_CR00102","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1021\/bc00018a001","volume":"3","author":"DS Wilbur","year":"1992","unstructured":"Wilbur DS (1992) Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjugate Chem 3:433\u2013470","journal-title":"Bioconjugate Chem"},{"key":"10_CR00103","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1110\/ps.051478705","volume":"14","author":"L Wang","year":"2005","unstructured":"Wang L, Amphlett G, Bl\u00e4ttler WA, Lambert JM, Zhang W (2005) Structural characterization of the maytansinoid-monoclonal antibody conjugate, huN901-DM1, by mass spectroscopy. Protein Sci 14:2436\u20132446","journal-title":"Protein Sci"},{"key":"10_CR00104","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0304-4165(66)90325-4","volume":"124","author":"A Jobbagy","year":"1966","unstructured":"Jobbagy A, Kiraly K (1966) Chemical characterization of fluorescein isothiocyanate\u2013protein conjugates. Biochim Biophys Acta 124:166","journal-title":"Biochim Biophys Acta"},{"key":"10_CR00105","unstructured":"Chen Q, Sowa D, Gabathuler R (2004) The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates. WO2004\/008101"},{"key":"10_CR00106","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1021\/bc200401b","volume":"23","author":"DS Wilbur","year":"2012","unstructured":"Wilbur DS, Chyan M-K, Nakamae H, Chen Y, Hamlin DK, Santos EB, Kornblit BT, Sandmaier BM (2012) Reagents for astatination of biomolecules. 6. An intact antibody conjugated with a maleimido-closo-decaborate(2-) reagent via sulfhydryl groups had considerably higher kidney concentrations than the same antibody conjugated with an isothiocyanato-closo-decaborate(2-) reagent via lysine amines. Bioconjugate Chem 23:409\u2013420","journal-title":"Bioconjugate Chem"},{"key":"10_CR00107","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.bmcl.2009.01.028","volume":"19","author":"JI Gavrilyuk","year":"2009","unstructured":"Gavrilyuk JI, Wuellner U, Barbas CF III (2009) \u03b2-Lactam-based approach for the chemical programming of aldolase antibody 38C2. Bioorg Med Chem Lett 19:1421\u20131424","journal-title":"Bioorg Med Chem Lett"},{"key":"10_CR00108","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1016\/j.bmcl.2009.05.047","volume":"19","author":"JI Gavrilyuk","year":"2009","unstructured":"Gavrilyuk JI, Wuellner U, Salahuddin S, Goswami RK, Sinha SC, Barbas CF III (2009) An efficient chemical approach to bispecific antibodies and antibodies of high valency. Bioorg Med Chem Lett 19:3716\u20133720","journal-title":"Bioorg Med Chem Lett"},{"key":"10_CR00109","doi-asserted-by":"crossref","unstructured":"Tietze LF, Goerlach A, Beller M (1988) Glycosidation, X. Synthesis of glycoconjugates of acetal-glycosides with lysine and tripeptides for selective cancer therapy. Liebigs Ann Chem 565\u2013577","DOI":"10.1002\/jlac.198819880613"},{"key":"10_CR001010","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1021\/bc034216c","volume":"16","author":"W Mier","year":"2005","unstructured":"Mier W, Hoffend J, Kr\u00e4mer S, Schuhmacher J, Hull WE, Eisenhut M, Haberkorn U (2005) Conjugation of DOTA using isolated phenolic active esters: the labeling and biodistribution of albumin as blood pool marker. Bioconjugate Chem 16:237\u2013240","journal-title":"Bioconjugate Chem"},{"key":"10_CR001011","unstructured":"Singh R, Kovtun Y, Wilhelm SD, Chari R (2010) Potent conjugates and hydrophilic linkers. WO2010\/126551"},{"key":"10_CR001012","unstructured":"Bouchard H, Commer\u00e7on A, Fromond C, Mikol V, Parker F, Sassoon I, Tavares D (2011) New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody. WO2011\/039721"},{"key":"10_CR001013","unstructured":"Bouchard H, Chari RVJ, Commer\u00e7on A, Deng Y (2009) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use. WO2009\/016516"},{"key":"10_CR001014","unstructured":"Li W, Fishkin NE, Zhao RY, Miller ML, Chari RVJ (2010) Novel benzodiazepine derivatives. WO2010\/091150"},{"key":"10_CR001015","unstructured":"Commer\u00e7on A, Gauzy-Lazo L (2011) Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents. WO2011\/023883"},{"key":"10_CR001016","first-page":"3336","volume":"53","author":"LM Hinman","year":"1993","unstructured":"Hinman LM, Hamann PR, Wallace R, Menendez AT, Durr FE, Upeslacis J (1993) Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics. Cancer Res 53:3336\u20133342","journal-title":"Cancer Res"},{"key":"10_CR001017","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1021\/bc0100206","volume":"13","author":"PR Hamann","year":"2002","unstructured":"Hamann PR, Hinman LM, Beyer CF, Lindh D, Upeslacis J, Flowers DA, Bernstein I (2002) An anti-CD33 antibody\u2212calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker. Bioconjugate Chem 13:40\u201346","journal-title":"Bioconjugate Chem"},{"key":"10_CR001018","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1021\/bc010021y","volume":"13","author":"PR Hamann","year":"2002","unstructured":"Hamann PR, Hinman LM, Hollander I, Beyer CF, Lindh D, Holcomb R, Hallett W, Tsou H-R, Upeslacis J, Shochat D, Mountain A, Flowers DA, Bernstein I (2002) Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody\u2013calicheamicin conjugate for treatment of acute myeloid leukemia. Bioconjugate Chem 13:47\u201358","journal-title":"Bioconjugate Chem"},{"key":"10_CR001019","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1158\/0008-5472.CAN-08-1776","volume":"68","author":"GD Lewis Phillips","year":"2008","unstructured":"Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Elaine Mai E, Bl\u00e4ttler WA, Lambert JM, Chari RVJ, Lutz RJ, Wong WLT, Jacobson FS, Koeppen H, Schwall RH, Kenkare-Mitra SR, Spencer SD, Sliwkowski MX (2008) Targeting HER2-positive breast cancer with Trastuzumab-DM1, an antibody\u2013cytotoxic drug conjugate. Cancer Res 68:9280\u20139290","journal-title":"Cancer Res"},{"key":"10_CR001020","unstructured":"Gauzy L, Zhao R, Deng Y, Li W, Bouchard H, Chari RVJ, Commer\u00e7on A (2007) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use. WO2007\/085930"},{"key":"10_CR001021","unstructured":"Chari RVJ, Zhao RY, Kovtun Y, Singh R, Widdison WC (2009) Cross-linkers and their uses. WO2009\/134977"},{"key":"10_CR001022","unstructured":"Singh R, Kovtun Y, Wilhelm SD, Chari RVJ (2009) Potent conjugates and hydrophilic linkers. WO2009\/134976"},{"key":"10_CR001023","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1021\/jm2002958","volume":"54","author":"RY Zhao","year":"2011","unstructured":"Zhao RY, Wilhelm SD, Audette C, Jones G, Leece BA, Lazar AC, Goldmacher VS, Singh R, Kovtun Y, Widdison WC, Lambert JM, Chari RVJ (2011) Synthesis and evaluation of hydrophilic linkers for antibody maytansinoid conjugates. J Med Chem 54:3606\u20133623","journal-title":"J Med Chem"},{"key":"10_CR001024","unstructured":"Steeves R, Lutz R, Chari R, Xie H, Kovtun Y (2005) Method of targeting specific cell populations using cell-binding agent maytansinoids conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates. WO2005\/037992"},{"key":"10_CR001025","unstructured":"Chari RVJ, Widdison WC (2004) Cytotoxic agents comprising new maytansinoids. US2004\/0235840"},{"key":"10_CR001026","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1021\/jm060319f","volume":"49","author":"WC Widdison","year":"2006","unstructured":"Widdison WC, Wilhelm SD, Cavanagh EE, Whiteman KR, Leece BA, Kovtun Y, Goldmacher VS, Xie H, Steeves RM, Lutz RJ, Zhao R, Wang L, Bl\u00e4ttler WA, Chari RVJ (2006) Semisynthetic maytansine analogues for the targeted treatment of cancer. J Med Chem 49:4392\u20134408","journal-title":"J Med Chem"},{"key":"10_CR001027","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1358\/dof.2010.035.06.1497487","volume":"35","author":"JM Lambert","year":"2010","unstructured":"Lambert JM (2010) Antibody-maytansinoid conjugates: a new strategy for the treatment of cancer. Drugs Future 35:471\u2013480","journal-title":"Drugs Future"},{"key":"10_CR001028","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1158\/1078-0432.CCR-11-0485","volume":"17","author":"V Blanc","year":"2011","unstructured":"Blanc V, Bousseau A, Caron A, Carrez C, Lutz RJ, Lambert JL (2011) SAR3419: an anti-CD19-maytansinoid immunoconjugate for the treatment of B-cell malignancies. Clin Cancer Res 17:6448\u20136458","journal-title":"Clin Cancer Res"},{"key":"10_CR001029","unstructured":"Bouchard H, Brun M-P, Commer\u00e7on A, Zhang J (2011) Novel conjugates, preparation thereof, and therapeutic use thereof. WO2011\/001052"},{"key":"10_CR001030","unstructured":"Widdison WC (2004) Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs. WO2004\/016801"},{"key":"10_CR001031","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1021\/bc100480a","volume":"22","author":"BA Kellogg","year":"2011","unstructured":"Kellogg BA, Garrett L, Kovtun Y, Lai KC, Leece B, Miller M, Payne G, Steeves R, Whiteman KR, Widdison W, Xie H, Singh R, Chari RVJ, Lambert JM, Lutz RJ (2011) Disulfide-linked antibody\u2212maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage. Bionconjugate Chem 22:717\u2013727","journal-title":"Bionconjugate Chem"},{"key":"10_CR001032","unstructured":"Carroll SF, Goff DA (1990) Hindered linking agents and methods. WO1990\/06774"},{"key":"10_CR001033","unstructured":"King DJ, Terrett JA, Gangwar S, Cardarelli JM, Raonaik C, Pan C (2009) Conjugates of anti-RG1 antibodies. WO2009\/073524"}],"container-title":["Methods in Molecular Biology","Antibody-Drug Conjugates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-541-5_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T18:47:25Z","timestamp":1674499645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-541-5_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9781627035408","9781627035415"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-541-5_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"1 July 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}